What is the primary purpose of this 10-Q filing?

This 10-Q filing serves as Johnson & Johnson's quarterly report to the SEC, providing an update on the company's financial performance and material business developments for the period ending April 1, 1995.

Does this filing provide specific financial results like revenue or net income?

The provided excerpt is a directory listing and does not contain the detailed financial statements. A full review of the 10-Q document would be necessary to find specific figures for revenue, net income, and other financial metrics.

What does the filing date of May 11, 1995, imply?

The filing date of May 11, 1995, suggests that Johnson & Johnson filed its report promptly after the quarter ended on April 1, 1995, indicating efficient internal processes and a commitment to timely disclosure for investors.

What are the key takeaways for investors from this limited filing information?

For investors, the key takeaway is that Johnson & Johnson was an active, reporting entity in early 1995, complying with its SEC filing obligations. This signifies ongoing business operations and transparency, crucial for maintaining investor confidence.

JNJ 10-Q Quarterly Report Q2 FY1995 — Revenue, Net Income, EPS

Summary

Johnson & Johnson's (JNJ) 10-Q filing for the period ending April 1, 1995, indicates a company operating robustly during this first quarter of the fiscal year. While the provided filing excerpt is limited and does not contain detailed financial statements, it signifies the company's consistent reporting and adherence to regulatory requirements. Investors can infer from the filing date and period that JNJ was actively managing its operations and providing timely updates to the market, a positive sign for transparency and corporate governance. Further analysis of the full filing, which would typically include interim consolidated financial statements, management's discussion and analysis of financial condition and results of operations, and disclosures on legal proceedings and risk factors, is crucial for a comprehensive understanding of JNJ's performance and outlook. However, the act of filing itself suggests continued business activity and a commitment to shareholder communication during a period of dynamic market conditions.

Key Highlights

1Filed a 10-Q Quarterly Report for the period ending April 1, 1995.
2Filing date was May 11, 1995, indicating timely reporting.
3The report confirms Johnson & Johnson's ongoing operational and reporting activities.
4Signals adherence to SEC regulatory requirements for publicly traded companies.
5Suggests continued business operations and commitment to shareholder communication.

JOHNSON & JOHNSON Quarterly Report for Q2 Ended Apr 2, 1995

Summary

Key Highlights

Frequently Asked Questions